Nephroprotection in Zucker diabetic fatty rats by vasopeptidase inhibition is partly bradykinin B2 receptor dependent.
about
The kallikrein-kinin system in diabetic nephropathyThe kallikrein-kinin system and oxidative stressThe roles of streptozotocin neurotoxicity and neutral endopeptidase in murine experimental diabetic neuropathy.Appropriateness of the Zucker Diabetic Fatty rat as a model for diabetic microvascular late complications.Vasopeptidase inhibitor ilepatril (AVE7688) prevents obesity- and diabetes-induced neuropathy in C57Bl/6J mice.Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic ratsRodent models for metabolic syndrome research.Effect of treatment of high fat fed/low dose streptozotocin-diabetic rats with Ilepatril on vascular and neural complicationsDiabetic nephropathy amelioration by a low-dose sitagliptin in an animal model of type 2 diabetes (Zucker diabetic fatty rat).Effects of Alpha-Lipoic Acid on Oxidative Stress and Kinin Receptor Expression in Obese Zucker Diabetic Fatty RatsBradykinin B2 receptors--a target in diabetic nephropathy.The kallikrein-kinin system in health and in diseases of the kidney.Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunctionVascular and neural dysfunctions in obese Zucker rats: effect of AVE7688.Enalaprilat-mediated activation of kinin b(1) receptors and vasodilation in the rat isolated perfused kidney.Beneficial effects of kinin B1 receptor antagonism on plasma fatty acid alterations and obesity in Zucker diabetic fatty rats.Renal gene expression profiling using kinin B1 and B2 receptor knockout mice reveals comparable modulation of functionally related genes
P2860
Q26827473-46A53615-81AA-42FD-95B0-D827E900E10BQ27000456-E8B817C4-6264-4974-A4F0-A30B103EEABDQ33635281-4F004EF7-77B5-41A7-898B-4E35D888FA6BQ34075371-117EC993-0CCD-4690-AEB8-C9D0C94B5C76Q34459107-6F9C4325-7D26-4913-9CF1-EA4B8CBA3A54Q34469283-2C0E2917-178C-4AC7-A763-BE832F2BBBC6Q34479248-AA3A7801-F5A3-4D4A-BD24-00A628001E32Q35256354-2787FDC0-6831-44BA-B182-8C494023A684Q35607330-C06EC1C9-4564-4AD3-9D89-473A516FC2C2Q36086898-59B58825-4FD2-46E6-A0D8-C43FA1FC0DD3Q36150886-3D4C139C-CDDD-4BA0-9975-0A9DE0B0D14BQ37070150-515A462F-3B5A-42DA-A648-F17DB8F5CAFFQ37155279-D4BE4FB3-C4B4-440C-89FF-2FB99AC4D939Q37226410-43AE1241-A771-49C4-88FA-64A9CF0C2288Q42745150-99E1B397-EF27-4F40-8D6D-D6FA43B12831Q53786362-A6605B00-FB9A-4463-A0F6-9AAC8129C02EQ56963504-46E992F7-1328-4A25-85C7-21358A8D7910
P2860
Nephroprotection in Zucker diabetic fatty rats by vasopeptidase inhibition is partly bradykinin B2 receptor dependent.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Nephroprotection in Zucker dia ...... dykinin B2 receptor dependent.
@en
Nephroprotection in Zucker dia ...... dykinin B2 receptor dependent.
@nl
type
label
Nephroprotection in Zucker dia ...... dykinin B2 receptor dependent.
@en
Nephroprotection in Zucker dia ...... dykinin B2 receptor dependent.
@nl
prefLabel
Nephroprotection in Zucker dia ...... dykinin B2 receptor dependent.
@en
Nephroprotection in Zucker dia ...... dykinin B2 receptor dependent.
@nl
P2093
P2860
P356
P1476
Nephroprotection in Zucker dia ...... adykinin B2 receptor dependent
@en
P2093
Andreas E Busch
Hans-Ludwig Schmidts
Stefan Schäfer
Wolfgang Linz
P2860
P356
10.1038/SJ.BJP.0705884
P407
P577
2004-08-02T00:00:00Z